|
⚲
|
| Keyboard |
| Kantoff Aaron
✚
|
|
|---|---|
| CIK # | 0001862734 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001862734] | |
| 4 | [0001862734] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kantoff Aaron | |
| Avalo Therapeutics Inc | |
| Tourmaline Bio Inc | |
| Centessa Pharmaceuticals PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Avalo Therapeutics Inc AVTX
Restricted Stock Units · derivative
|
2026-03-28 | Option exercise | 3,166 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2026-03-28 | Option exercise | 3,166 | ||
|
Tourmaline Bio Inc TRML
Employee Stock Option (Right to Buy) · derivative
|
2025-10-28 | Disposed to issuer | 10,000 | ||
|
Tourmaline Bio Inc TRML
Employee Stock Option (Right to Buy) · derivative
|
2025-10-28 | Disposed to issuer | 16,800 | ||
|
Tourmaline Bio Inc TRML
Common Stock
|
2025-10-28 | Tender | 88,281 | ||
|
Tourmaline Bio Inc TRML
Common Stock
|
2025-10-24 | Gift | 5,000 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2025-06-17 | Grant | 20,100 | $0.00 | |
|
Tourmaline Bio Inc TRML
Stock Option (Right to Buy) · derivative
|
2025-06-04 | Grant | 16,800 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Restricted Stock Units · derivative
|
2025-03-28 | Option exercise | 3,167 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2025-03-28 | Option exercise | 3,167 | ||
|
Avalo Therapeutics Inc AVTX
Stock Option (Right to Buy) · derivative
|
2024-08-13 | Grant | 24,600 | $0.00 | |
|
Avalo Therapeutics Inc AVTX
Restricted Stock Units · derivative
|
2024-08-13 | Grant | 9,500 | $0.00 | |
|
Tourmaline Bio Inc TRML
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 10,000 | $0.00 | |
|
Tourmaline Bio Inc TRML
Common Stock
|
2023-10-24 | Buy | 7,500 | $11.86 | 88,950 |
|
Tourmaline Bio Inc TRML
Stock Option (Right to Buy) · derivative
|
2023-10-23 | Grant | 10,000 | $0.00 | |
|
Tourmaline Bio Inc TRML
Common Stock
|
2023-10-19 | Grant | 37,891 | ||
|
Tourmaline Bio Inc TRML
Stock Option (Right to Buy) · derivative
|
2023-10-19 | Grant | 37,890 | ||
|
Centessa Pharmaceuticals PLC CNTA
Ordinary Shares
|
2021-11-18 | Buy | 10,000 | $11.99 | 119,900 |